← Back to Search

Electrophysiological Study for Atrioventricular Nodal Reentry Tachycardia (AVNRT Trial)

N/A
Waitlist Available
Led By Stavros Stavrakis, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 16-80
Patient scheduled for electrophysiology study and catheter ablation for supraventricular tachycardia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up unk
Awards & highlights

AVNRT Trial Summary

This trial is testing what causes a heart condition called AV nodal reentrant tachycardia.

Who is the study for?
This trial is for people aged 16-80 who have had at least one documented episode of a rapid heartbeat condition called AV nodal reentrant tachycardia and are scheduled for a special heart study and treatment. It's not for those under 16 or over 80, pregnant individuals, patients with conditions that could prolong the procedure or increase X-ray exposure, those who've had prior treatments with long radiation exposure, or if they can't come back for follow-up.Check my eligibility
What is being tested?
The study aims to understand the factors involved in AV nodal reentrant tachycardia by using an invasive cardiac procedure known as an electrophysiological study. Participants will undergo this specialized heart test to identify what triggers their rapid heartbeat.See study design
What are the potential side effects?
While specific side effects aren't listed here, invasive cardiac procedures like electrophysiological studies may include risks such as bleeding at the catheter site, infection, damage to blood vessels or heart tissue, irregular heartbeats, and rarely more serious complications.

AVNRT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 16 and 80 years old.
Select...
I am scheduled for a procedure to treat my rapid heartbeat.

AVNRT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~unk
This trial's timeline: 3 weeks for screening, Varies for treatment, and unk for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
raise the frequency of success to more than 98%

AVNRT Trial Design

1Treatment groups
Experimental Treatment
Group I: Study ArmExperimental Treatment1 Intervention
Mapping and Ablation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cardiac Invasive Electrophysiological Study
2004
N/A
~50

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,589 Total Patients Enrolled
Stavros Stavrakis, MDPrincipal InvestigatorUniversity of Oklahoma
6 Previous Clinical Trials
308 Total Patients Enrolled
Deborah Lockwood, M.D.Principal InvestigatorUniversity of Oklahoma

Media Library

Cardiac Invasive Electrophysiological Study Clinical Trial Eligibility Overview. Trial Name: NCT00618683 — N/A
Atrioventricular Nodal Reentry Tachycardia Research Study Groups: Study Arm
Atrioventricular Nodal Reentry Tachycardia Clinical Trial 2023: Cardiac Invasive Electrophysiological Study Highlights & Side Effects. Trial Name: NCT00618683 — N/A
Cardiac Invasive Electrophysiological Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT00618683 — N/A
~2 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top